ArticleJournal of current ophthalmology
Relationship between Central Corneal Thickness and Endothelial Cell Density in Individuals with Primary Glaucoma and the General Population Living at High Altitudes.
Article in Journal of current ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the impact of high-altitude living on central corneal thickness (CCT) and corneal endothelial cell density (ECD) in individuals diagnosed with primary glaucoma, compared to age-matched healthy controls. Methods: This prospective study was conducted in the Lesser Himalayan region, at an average altitude between 2800 and 4200 m above sea level. The study population consisted of 120 eyes from 120 patients diagnosed with primary glaucoma who were permanent residents above 2000 meters. Subgroup 1A included individuals with primary open-angle glaucoma, whereas Subgroup 1B comprised those with angle closure glaucoma. Age-matched healthy subjects constituted the control group (Group 2). Results: Individuals with glaucoma residing above 3800 m exhibited a mean CCT reduction of 11 ± 5.3 μm and a mean ECD decrease of 145 ± 22 cells/mm Conclusions: High-altitude residence may exacerbate corneal changes in patients with primary glaucoma, with potential implications for disease progression and management. The findings highlight the need for altitude-specific considerations in glaucoma assessment and treatment and underscore the importance of regular corneal evaluation in these populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.